Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine-Reference-Cited by-同舟云学术

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine

Published:2016-09-01 Issue:6 Volume:1 Page:673
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Alexander John H.¹,Andersson Ulrika²,Lopes Renato D.¹,Hijazi Ziad²,Hohnloser Stefan H.³,Ezekowitz Justin A.⁴,Halvorsen Sigrun⁵,Hanna Michael⁶,Commerford Patrick⁷,Ruzyllo Witold⁸,Huber Kurt⁹,Al-Khatib Sana M.¹,Granger Christopher B.¹,Wallentin Lars²,

Affiliation:

1. Duke Clinical Research Institute, Duke Health, Durham, North Carolina

2. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

3. Division of Clinical Electrophysiology, Goethe University, Frankfurt, Germany

4. Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada

5. Department of Cardiology, Oslo University Hospital and University of Oslo, Oslo, Norway

6. Bristol-Myers Squibb, Princeton, New Jersey

7. Department of Medicine, University of Cape Town, Cape Town, South Africa

8. Institute of Cardiology, Warsaw, Poland

9. Third Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenspital, Vienna, Austria

Publisher

American Medical Association (AMA)